1. Lagari VS, Levis S. (2014). Phytoestrogens for menopausal bone loss and climacteric symptoms. The Journal of steroid biochemistry and molecular biology 139:294-301.
2. du Bois A, Heitz F, Harter P. (2013). Fertility-sparing surgery in ovarian cancer: a systematic review. Onkologie 36(7-8):436-43.
3. Leslie WD, Brennan SL, Lix LM, Johansson H, Oden A, et al. (2013). Direct comparison of eight national FRAXAŽ tools for fracture prediction and treatment qualification in Canadian women. Archives of osteoporosis 8:145.
4. Chen W, Shi Z. (2013). Trend in gender disparities of BMI and height between 2004 and 2011 among adolescents aged 17-18 years in Changzhou China. Asia Pacific journal of clinical nutrition 22(3):466-73.
5. Lekamwasam S. (2013). Sri Lankan FRAX model and country-specific intervention thresholds. Archives of osteoporosis 8:148.
6. Geffen DB, Tokar M, Abu-Ghanem S, Braunstein R, Koretz M, et al. (2013). Adjuvant aromatase inhibitor therapy in patients with stage I breast cancer at a regional oncology center in Israel: implementation of a ''switching'' policy in postmenopausal patients after initial tamoxifen. Oncology 85(3):145-52.
7. Nagpal S, Walia L. (2013). Haemodynamic responses to exercise stress test in postmenopausal women with coronary artery disease. Journal of the Indian Medical Association 111(1):24-7.
8. D''Amelio P. (2013). The immune system and postmenopausal osteoporosis. Immunological investigations 42(7):544-54.
9. Valerio CS, Trindade AM, Mazzieiro ET, Amaral TP, Manzi FR, et al. (2013). Use of digital panoramic radiography as an auxiliary means of low bone mineral density detection in post-menopausal women. Dento maxillo facial radiology 42(10):20120059.
10. Sparrow R. (2013). Gender eugenics? The ethics of PGD for intersex conditions. The American journal of bioethics : AJOB 13(10):29-38.